FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064383026> ?p ?o ?g. }

• W2064383026 endingPage "152" @default.
• W2064383026 startingPage "142" @default.
• W2064383026 abstract "All-trans retinoic acid (ATRA) promotes terminal differentiation in epithelial cells and anti-angiogenesis and thus, may have beneficial effects in an intervention therapy for prostate cancer.We used the autochthonous spontaneous transgenic adenocarcinoma of the mouse prostate (TRAMP) model system to test the ability of ATRA to prevent initiation and progression of prostate cancer in a pre-clinical setting.Initial studies demonstrated that exposure of TRAMP-derived C2N prostate tumor cells to ATRA in vitro decreased total viable cell numbers with a concomitant decrease in the fraction of cells in S phase. When TRAMP mice were treated in vivo with ATRA for either 6 or 8 weeks at low, medium, or high dose, mice on average presented with lower grade and more differentiated tumors. However, ATRA therapy conferred no significant protection on incidence of tumors or frequency of metastasis at any dose. Nevertheless, we were able to observe a significant decrease in the expression of synaptophysin, a marker of neuroendocrine differentiation, in tumors of mice receiving the highest dose of ATRA. As well, expression of the cell cycle inhibitor p21 was found to be elevated only in well-differentiated tumors of mice, treated with ATRA while expression of p27, was found to be elevated only in the poorly differentiated tumors.Collectively, our in vitro and in vivo data demonstrates that ATRA was able to slow prostate tumor cell proliferation, induce apoptosis, and block the emergence of the neuroendocrine phenotype. Furthermore, our study suggests the differential regulation of p21 and p27 as a molecular mechanism whereby ATRA intervention therapy can inhibit the natural history of spontaneous prostate cancer." @default.
• W2064383026 created "2016-06-24" @default.
• W2064383026 creator A5006081813 @default.
• W2064383026 creator A5040924182 @default.
• W2064383026 creator A5056644220 @default.
• W2064383026 creator A5067861660 @default.
• W2064383026 creator A5068001060 @default.
• W2064383026 date "2004-01-01" @default.
• W2064383026 modified "2023-10-17" @default.
• W2064383026 title "Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer" @default.
• W2064383026 cites W1967858466 @default.
• W2064383026 cites W1969955593 @default.
• W2064383026 cites W1974171881 @default.
• W2064383026 cites W1975042281 @default.
• W2064383026 cites W1989793213 @default.
• W2064383026 cites W1994479896 @default.
• W2064383026 cites W1995369328 @default.
• W2064383026 cites W2001334796 @default.
• W2064383026 cites W2010057554 @default.
• W2064383026 cites W2014366669 @default.
• W2064383026 cites W2031208489 @default.
• W2064383026 cites W2032263711 @default.
• W2064383026 cites W2047236275 @default.
• W2064383026 cites W2064213519 @default.
• W2064383026 cites W2074432871 @default.
• W2064383026 cites W2083499460 @default.
• W2064383026 cites W2084541894 @default.
• W2064383026 cites W2085574028 @default.
• W2064383026 cites W2098882558 @default.
• W2064383026 cites W2107856889 @default.
• W2064383026 cites W2111686546 @default.
• W2064383026 cites W2126006099 @default.
• W2064383026 cites W2131036707 @default.
• W2064383026 cites W2136711352 @default.
• W2064383026 cites W2169099825 @default.
• W2064383026 cites W2201035906 @default.
• W2064383026 cites W268102757 @default.
• W2064383026 doi "https://doi.org/10.1002/pros.20097" @default.
• W2064383026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15305337" @default.
• W2064383026 hasPublicationYear "2004" @default.
• W2064383026 type Work @default.
• W2064383026 sameAs 2064383026 @default.
• W2064383026 citedByCount "52" @default.
• W2064383026 countsByYear W20643830262012 @default.
• W2064383026 countsByYear W20643830262013 @default.
• W2064383026 countsByYear W20643830262014 @default.
• W2064383026 countsByYear W20643830262015 @default.
• W2064383026 countsByYear W20643830262016 @default.
• W2064383026 countsByYear W20643830262017 @default.
• W2064383026 countsByYear W20643830262019 @default.
• W2064383026 countsByYear W20643830262020 @default.
• W2064383026 countsByYear W20643830262021 @default.
• W2064383026 countsByYear W20643830262022 @default.
• W2064383026 countsByYear W20643830262023 @default.
• W2064383026 crossrefType "journal-article" @default.
• W2064383026 hasAuthorship W2064383026A5006081813 @default.
• W2064383026 hasAuthorship W2064383026A5040924182 @default.
• W2064383026 hasAuthorship W2064383026A5056644220 @default.
• W2064383026 hasAuthorship W2064383026A5067861660 @default.
• W2064383026 hasAuthorship W2064383026A5068001060 @default.
• W2064383026 hasConcept C121608353 @default.
• W2064383026 hasConcept C126322002 @default.
• W2064383026 hasConcept C134018914 @default.
• W2064383026 hasConcept C150903083 @default.
• W2064383026 hasConcept C190283241 @default.
• W2064383026 hasConcept C207001950 @default.
• W2064383026 hasConcept C2776235491 @default.
• W2064383026 hasConcept C2779013556 @default.
• W2064383026 hasConcept C2779963572 @default.
• W2064383026 hasConcept C2780192828 @default.
• W2064383026 hasConcept C2780341458 @default.
• W2064383026 hasConcept C2780940892 @default.
• W2064383026 hasConcept C2781121885 @default.
• W2064383026 hasConcept C2781182431 @default.
• W2064383026 hasConcept C502942594 @default.
• W2064383026 hasConcept C54355233 @default.
• W2064383026 hasConcept C55493867 @default.
• W2064383026 hasConcept C71924100 @default.
• W2064383026 hasConcept C81885089 @default.
• W2064383026 hasConcept C86803240 @default.
• W2064383026 hasConceptScore W2064383026C121608353 @default.
• W2064383026 hasConceptScore W2064383026C126322002 @default.
• W2064383026 hasConceptScore W2064383026C134018914 @default.
• W2064383026 hasConceptScore W2064383026C150903083 @default.
• W2064383026 hasConceptScore W2064383026C190283241 @default.
• W2064383026 hasConceptScore W2064383026C207001950 @default.
• W2064383026 hasConceptScore W2064383026C2776235491 @default.
• W2064383026 hasConceptScore W2064383026C2779013556 @default.
• W2064383026 hasConceptScore W2064383026C2779963572 @default.
• W2064383026 hasConceptScore W2064383026C2780192828 @default.
• W2064383026 hasConceptScore W2064383026C2780341458 @default.
• W2064383026 hasConceptScore W2064383026C2780940892 @default.
• W2064383026 hasConceptScore W2064383026C2781121885 @default.
• W2064383026 hasConceptScore W2064383026C2781182431 @default.
• W2064383026 hasConceptScore W2064383026C502942594 @default.
• W2064383026 hasConceptScore W2064383026C54355233 @default.
• W2064383026 hasConceptScore W2064383026C55493867 @default.
• W2064383026 hasConceptScore W2064383026C71924100 @default.

• next